After mild traumatic brain injury (TBI), a molecule called complement factor C1q may play a role in the secondary effects of brain injury, such as sleep disruption, epileptic activity, and ...

In this article, ACROBiosystems discusses how the complement cascade and it's various components could potentially be leveraged for therapeutic potential in COVID-19, cancer and general inflammation.

To investigate, first author Scott-Hewitt isolated synaptosomes from wild-type mice and immunoprecipitated C1q from them, checking to see what else came along for the ride. Unexpectedly, C1q from year ...